Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
422
datasets available to search
ShareScore release 0.9.0
Dataset results
422 results for “Semaglutide”
The short-term cost-effectiveness of once-weekly semaglutide versus once-weekly dulaglutide for the treatment of type 2 diabetes mellitus in Colombian adults
<p>Dataset used for the study titled "A relative cost of control analyses of once weekly semaglutide versus dulaglutide for the treatment of type 2 diabetes mellitus in Colombian adults"</p>
Study of Semaglutide for Non-Alcoholic Fatty Liver Disease (NAFLD), a Metabolic Syndrome With Insulin Resistance, Increased Hepatic Lipids, and Increased Cardiovascular Disease Risk (The SLIM LIVER St
ClinicalTrials.gov study NCT04216589. IPD Sharing: YES. Countries: 2. Publications: 2.
Pattern of Using Semaglutide Injection among the Population in Saudi Arabia
<p>Semaglutide injection with lifestyle intervention has been shown to be more effective than lifestyle modification alone. However, pharmacological intervention shows fewer side effects than bariatric surgery. This cross-sectional study was conducted among the general population in Saudi Arabia. A self-administered questionnaire was sent among the targeted population using an online survey. The questionnaire includes socio-demographic data (e.g., age, gender, marital status, etc.), general awareness about Semaglutide injection, and a 4-item questionnaire to measure the knowledge about Semaglutide. Of the 382 participants, 52.4% were males, and 44.8% were aged between 18 to 30 years old. The level of knowledge about Semaglutide injection was poor among 69.4%, while the rest had good knowledge (30.6%). The overall mean knowledge score was 1.62 (SD 1.26) out of 4 points. Younger participants, gender female, unmarried, unemployed, normal or underweight, aware of Semaglutide injection, previous usage of Semaglutide, satisfaction with Semaglutide, and knowledge about combined benefits (diabetes control and weight loss) of Semaglutide injections were the factors associated with increased knowledge score. The knowledge of the general population regarding Semaglutide injection was lacking. Younger female participants with normal body weight who were satisfied with Semaglutide were identified as the most significant users of Semaglutide injections. Further investigations are needed to extract more data about the general population's knowledge of Semaglutide injections.</p>
Investigation of Efficacy and Safety of Three Dose Levels of Subcutaneous Semaglutide Once Daily Versus Placebo in Subjects With Non-alcoholic Steatohepatitis.
ClinicalTrials.gov study NCT02970942. IPD Sharing: YES. Countries: 17. Publications: 7.
A Trial Comparing the Safety and Efficacy of Semaglutide Once Weekly in Monotherapy or in Combination With One OAD in Japanese Subjects With Type 2 Diabetes
ClinicalTrials.gov study NCT02207374. IPD Sharing: Not stated. Countries: 1. Publications: 4.
Two-year Research Study Investigating How Well Semaglutide Works in People Suffering From Overweight or Obesity
ClinicalTrials.gov study NCT03693430. IPD Sharing: YES. Countries: 5. Publications: 5.
A Research Study Comparing a New Medicine Oral Semaglutide to Sitagliptin in People With Type 2 Diabetes
ClinicalTrials.gov study NCT04017832. IPD Sharing: YES. Countries: 9. Publications: 1.
A Research Study to See How Semaglutide Helps People With Excess Weight and Type 2 Diabetes Lose Weight
ClinicalTrials.gov study NCT05649137. IPD Sharing: YES. Countries: 8. Publications: 1.
A Heart Disease Study of Semaglutide in Patients With Type 2 Diabetes
ClinicalTrials.gov study NCT03914326. IPD Sharing: YES. Countries: 34. Publications: 5.
Efficacy and Safety of Oral Semaglutide Using a Flexible Dose Adjustment Based on Clinical Evaluation Versus Sitagliptin in Subjects With Type 2 Diabetes Mellitus.
ClinicalTrials.gov study NCT02849080. IPD Sharing: YES. Countries: 10. Publications: 7.
Research Study Investigating How Well Semaglutide Works in People Suffering From Overweight or Obesity
ClinicalTrials.gov study NCT03548987. IPD Sharing: YES. Countries: 10. Publications: 6.
Safety and Efficacy of Oral Semaglutide Versus Dulaglutide Both in Combination With One OAD (Oral Antidiabetic Drug) in Japanese Subjects With Type 2 Diabetes
ClinicalTrials.gov study NCT03015220. IPD Sharing: YES. Countries: 1. Publications: 5.
Efficacy and Safety of Oral Semaglutide Versus Empagliflozin in Subjects With Type 2 Diabetes Mellitus
ClinicalTrials.gov study NCT02863328. IPD Sharing: Not stated. Countries: 12. Publications: 8.
Research Study Looking at How Well Semaglutide Works in People Living With Obesity and Prediabetes
ClinicalTrials.gov study NCT05040971. IPD Sharing: YES. Countries: 5. Publications: 1.
Research Study Looking at How Well Semaglutide Works in People Suffering From Obesity and Knee Osteoarthritis
ClinicalTrials.gov study NCT05064735. IPD Sharing: YES. Countries: 11. Publications: 1.
A Research Study to See How a New Weekly Insulin, Insulin Icodec When Given Along With Semaglutide Helps in Reducing the Blood Sugar Level in Patients With Type 2 Diabetes
ClinicalTrials.gov study NCT05813912. IPD Sharing: YES. Countries: 5. Publications: 0.
A Study to Evaluate the Effect of the Experimental GLP-1 Drug PF-07081532 on Blood Levels of Common Birth Control Pills, and Drugs Omeprazole and Midazolam, and Effect of GLP-1 Drug Semaglutide on Mid
ClinicalTrials.gov study NCT05671653. IPD Sharing: NO. Countries: 1. Publications: 0.
Safety and Efficacy of Bimagrumab and Semaglutide in Adults Who Are Overweight or Obese
ClinicalTrials.gov study NCT05616013. IPD Sharing: YES. Countries: 3. Publications: 1.
A Randomised Controlled Clinical Trial in Type 2 Diabetes Comparing Semaglutide to Placebo and Liraglutide
ClinicalTrials.gov study NCT00696657. IPD Sharing: Not stated. Countries: 14. Publications: 1.
Efficacy and Safety of Semaglutide Once Weekly Versus Insulin Glargine Once Daily as add-on to Metformin With or Without Sulphonylurea in Insulin-naïve Subjects With Type 2 Diabetes
ClinicalTrials.gov study NCT02128932. IPD Sharing: Not stated. Countries: 15. Publications: 12.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.